PerpEquities

Equity

WuXi Biologics (Cayman) Inc. (WUXIBIO) perpetual futures

WUXIBIO perpetual futures on 5 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade WUXIBIOUSDT.

WuXi Biologics provides integrated biologics services across discovery, development and large-scale manufacturing, plus CDMO work for vaccines, serving clients in China, North America and Europe.

$5.94+2.2%
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

venue perp mark · MEXC (WUXIBIO/USDT)
Auto: highest-volume live perp venue

Trading data

Perpetual market activity

5/5 live markets
Venues
5
Live markets
5/5
24h volume
$279.1K
Open interest
$45.4K
Best liquidity
$38.3K
MEXC
Tightest spread
+20.0 bps
OKX
Highest volume
$103.3K
MEXC
Settlement mix
USDT · 5/5
Perp/spot vol.
0.00x
Spot volume $169.5M
OI / float
0.00%
Float $22.3B
Spot performance
1D-4.38%
5D-4.61%
1M-3.91%
6M+38.78%
YTD+48.66%
1Y+44.44%

Venue matrix

5 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
MEXCTradeWUXIBIO/USDTTrading$5.940.0% APR
0.000% every 8h
+20.2 bps$38.3K$103.3K$3.6KUSDT20x
Gate.ioTradeWUXIBIO/USDTTrading$5.950.0% APR
0.000% every 8h
+124.3 bps$284.5$56.8K$2.8KUSDT20x
LBankTradeWUXIBIO/USDTTrading$5.940.0% APR
0.000% every 8h
+60.6 bps$25.6K$46.4K$4KUSDT20x
HTXTradeWUXIBIO/USDTTrading$5.950.0% APR
0.000% every 8h
+351.6 bps$0$44K$5.4KUSDT-
OKXTradeWUXIBIO/USDTTrading$5.950.0% APR
0.000% every 8h
+20.0 bps$2.7K$28.7K$29.7KUSDT10x

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

Thin liquidity · 2 of 5 venues absorb $10k · Typical cost: +58.8 bps – +87.2 bps

Cheapest execution: MEXC · +44.6 bps

Too thin: OKX

No fresh book data: Gate.io, HTX

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

WUXIBIO

Tightest spread

WUXIBIO

Highest volume

WUXIBIO

Funding history

Stored venue snapshots by market

Company financials

Financials at a glance

Last report Q2 '26 · filed 2026-06-30 · next report 2027-03-23 · Updated 5h ago
All financials →

Valuation & key figures

Market cap
$24.3B
Updated 5h ago
Revenue
CN¥23.6B
Trailing 12 months
Revenue growth
+20%
FY2026 consensus
Profit margin
21.2%
Net income / revenue, TTM
P/E
32.9×
P/S
6.9×
Price / sales, TTM
Peer P/E
28.3×
Similar listed perps
EV / EBITDA
16.5×
TTM
Free cash flow
CN¥4.42B
Trailing 12 months
Net income
CN¥5.01B
Trailing 12 months
Revenue estimate
CN¥26.1B
FY2026 consensus
Earnings
2027-03-23
Revenue est. $2.08B · Updated 5h ago
Dividend
–
No dividend
Revenue (TTM)CN¥23.6B+17.8% vs a year agoLast 2 half-years; bars = each half-year
Operating margin (TTM)32.4%+3.0 pp vs a year agoOperating income CN¥7.64B
Net income (TTM)CN¥5.01B+19.4% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)CN¥4.42B+151.5% vs a year agoCapex CN¥4.63B
Diluted EPS (TTM)CN¥1.19+21.4% vs a year agoSum of the last 2 half-years
Net cashCN¥10.3B+58.9% vs a year agoCash + short-term investments - debt
  • Revenue growth accelerating: 18.4% year on yearQ2 '26 revenue CN¥11.8B, against an average of 13.1% over the four half-years before.
  • Operating margin 32.4% (TTM), +3.0 pp on a year agoOperating income grew 30.0% while revenue grew 17.8%.
  • Capex 19.6% of revenue (a year ago 19.8%)CN¥4.63B invested in the last 2 half-years (+16.8% on a year earlier). Free cash flow CN¥4.42B = 88.3% of net income.
  • Returned CN¥1.86B to shareholders = 42.1% of free cash flowBuybacks CN¥1.86B (a year earlier CN¥1.56B), dividends CN¥0, stock-based pay CN¥455M (TTM).

Revenue, operating income and growth

quarterly
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates

Next catalyst

Catalysts

Earnings
2027-03-23
Revenue est. $2.08B · Updated 5h ago

No unusual perp activity right now.

Reference data

Market context

Reference market

Closed
Hong Kong Stock Exchange
Regular hours
CLOSED – CLOSED GMT+8
Next holiday
Dec 24, 2026 · Christmas Eve (half day)

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20260.22$3.9B+20%16
FY 20270.27$4.7B+20%17
FY 20280.33$5.6B+20%17
FY 20290.41$6.4B+14%12
FY 20300.46$7.5B+16%7
Q4 20260.11$2.1B+19%1
Source: FMP · Consensus

Company events

6
2027-03-23EarningsActual - / Estimate 0.856-
2026-08-25EarningsActual 0.669 / Estimate 0.519Beat
2026-03-24EarningsActual 0.679 / Estimate 0.705Miss
2025-08-19EarningsActual 0.599 / Estimate 0.49Beat
2025-03-24EarningsActual 0.24 / Estimate 0.469Miss
2024-08-21EarningsActual 0.375 / Estimate 0.44Miss

Peer comparison

Similar listed perps

Company data

Company intelligence

Updated: Nov 15, 2026, 07:15 AM UTC

Company profile

Sector
Healthcare
Industry
Biotechnology
Chief executive
Zhisheng Chen
Employees
14,705
IPO date
Jun 13, 2017
Country
CN
Exchange
Hong Kong Stock Exchange
Website
Altman Z-scorei9.7
Piotroski scorei8/9
Overall ratingiB+
Owner earningsiCN¥4.68BCN¥1.12 per share

Rating factors

Return on equityi
4/5
Return on assetsi
5/5
Debt to equityi
4/5
Price to earningsi
2/5
Price to booki
3/5
Market cap history
HK$191.48B-1.6%Aug 2026 – Nov 2026
HK$182.71BHK$204.83BHK$226.95BHigh: HK$226.95B · 2026-10-05Low: HK$182.71B · 2026-11-02Latest: HK$191.48B · 2026-11-13Aug 2026Sep 2026Oct 2026Nov 2026
Latest: HK$191.48B · 2026-11-13High: HK$226.95B · 2026-10-05Low: HK$182.71B · 2026-11-02
Largest fund holders
FundWeightShares held
VXUS0.06%55.2M
VWO0.22%52.7M
IEMG0.15%40.3M
VWIGX0.58%34.9M
2800.HK1.12%31M
AVEM0.26%12.1M
EIMI.L0.16%12M
EIMU DE0.16%11.9M
BBAX0.93%11.1M
EEM0.18%8.9M
VEU0.06%8.9M
WCMI2.35%8.7M

Analyst track record

How the analysts covering WUXIBIO have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings00
Analysts00
Buy / hold / sell––
Upgrades / downgrades / initiations0 / 0 / 00 / 0 / 0
Price targets hit / missed––
Avg. return after a rating (TipRanks)––
Best / worst call– / –– / –

After buy calls on this stock: not enough measured cases yet

TipRanks data · computed Nov 11, 2026 · 0 ratings

Frequently asked questions

Where can I trade WUXIBIO perpetual futures?

WuXi Biologics (Cayman) Inc. (WUXIBIO) perpetual futures trade on 5 crypto venues, including MEXC, Gate.io, LBank. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade WUXIBIO around the clock?

Yes. Unlike the underlying stock, WUXIBIO perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on WUXIBIO perpetuals?

Right now the WUXIBIO perp funding rate is 0.0% annualized (venue median), ranging from 0.0% to 0.0% across 5 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the WUXIBIO perp price compare to the WuXi Biologics (Cayman) Inc. stock?

The venue-median WUXIBIO perp mark is $5.95 versus a reference stock price of $5.94, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a WUXIBIO perpetual future?

A WUXIBIO perpetual is a derivative that tracks the price of WuXi Biologics (Cayman) Inc. with no expiry date. It lets you take long or short exposure to WuXi Biologics (Cayman) Inc. on crypto venues, around the clock.

What is WUXIBIOUSDT perpetual?

WUXIBIOUSDT is the symbol most crypto exchanges use for the WuXi Biologics (Cayman) Inc. perpetual settled in USDT (Tether). It tracks the WUXIBIO share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

WUXIBIO perpetuals · perpequities.comWUXIBIO perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/wuxibio-perp"><img src="https://perpequities.com/badge/wuxibio-perp.svg" width="240" height="64" alt="WUXIBIO perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of WUXIBIO perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for WUXIBIO — one email every Sunday.

Watchlist and alerts

Price and funding alerts for WUXIBIO, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X